Appointment of New Directors
Kobe, Japan -April 15, 2024
FOR IMMEDIATE RELEASEOn April 13, 2022, Yoshinori Bamba was appointed Representative Director and CEO and Kazuko Ando wasappointed Director and COO a of Bio Palette Co., Ltd (Head Office: Chuo-ku, Kobe City).
Name

New Job Title

Previous Job Title

Yoshinori Bamba

Representative Director and CEO

Executive Officer COO

Kazuko Ando

Director and COO

Executive Officer CBO

Yoshinori Bamba joined Bio Palette as Executive Officer and Chief Operating Officer in January 2024. Prior tojoining our team, Mr. Bamba was a director at PURMX Therapeutics, Inc., where he oversaw businessdevelopment and fundraising efforts. At J-Pharma Co., Ltd., his responsibilities included devising effective
business strategies and successfully leading the out-licensing of in-house developed compounds to otherpharmaceutical companies. Earlier in his career, he played a pivotal role in product launches at CSL Behring
K.K.. Mr. Bamba's professional journey began at Kyowa Kirin Co., Ltd., where he contributed to the launch of
two drugs while focusing on pharmacokinetics and clinical pharmacology. His academic accomplishmentsinclude a master's degree from the Tokyo University of Pharmacy and Life Sciences in 2007 and an MBA in
2013. His expertise spans pharmaceutical development, particularly in pharmacokinetics and clinicalpharmacology, along with a wealth of experience in management, strategy, and business development within
the biotech sector.
Kazuko Ando joined Bio Palette as Executive Officer and Chief Business Officer in November 2023. Before
joining our team, Ms. Ando showcased her exceptional abilities as the Executive VP Head of Legal and Business
Development at Healios NA, Inc. from 2022, a subsidiary of HEALIOS K.K. Her illustrious career at Healios,spanning from 2014, culminated in her leadership of the Legal Group and Business Development. BeforeHealios, Ms. Ando honed her expertise in intellectual property at GREE, Inc., Sony Corporation, and Suntory
Holding Limited, obtaining her patent attorney certification in 2006. Ms. Ando holds a master's degree from
Osaka University, where she was the top Biological Sciences graduate in 2001. Her extensive experience
encompasses pivotal roles in major corporations and biotech ventures, focusing on intellectual property, legalaffairs, and business development.
With this new appointment, Bio Palette is poised to further strengthen our organizational structure and expansion.
Our unwavering commitment to innovation in therapeutics, driven by our unique genome editing technology,

remains steadfast. We are dedicated to applying this pioneering technology across various business sectors. Bio
Palette administrative, research, and development departments, with our management team working collectivelyto achieve our ambitious goals.
For inquiries regarding this release, please contact us at:
Bio Palette Co., Ltd.
Email: contact@biopalette.co.jp
About Bio Palette Co., Ltd.:
Bio Palette is a leading biotechnology company headquartered in Kobe, Japan, dedicated to revolutionizing
healthcare through innovative microbiome therapeutics powered by cutting-edge genome editing technology.
Our mission is to harness the potential of the microbiome to improve human health and quality of life. Learn
more at www.biopalette.co.jp.